clofibric acid has been researched along with proadifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, B; Brown, P; Byers, LW; Capdevila, J; Dowell, R; Muirhead, E; Pitcock, JA | 1 |
| Iley, J; Mendes, E; Moreira, R; Souza, S | 1 |
2 other study(ies) available for clofibric acid and proadifen
| Article | Year |
|---|---|
Effect of cytochrome P-450 induction and inhibition on the antihypertensive function of the kidney.
Topics: Animals; Blood Pressure; Clofibric Acid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Induction; Fibric Acids; Hypertension, Renovascular; Hypertrophy; Hypolipidemic Agents; Liver; Male; Phenobarbital; Proadifen; Rats; Rats, Inbred Strains; Reference Values | 1987 |
Cleavage of tertiary amidomethyl ester prodrugs of carboxylic acids by rat liver homogenates.
Topics: Amides; Animals; Benzoic Acid; Carboxylic Acids; Clofibric Acid; Diclofenac; Drug Interactions; Esters; Hydrolases; Hydrolysis; Ibuprofen; In Vitro Techniques; Liver; Male; Naproxen; Physostigmine; Proadifen; Probenecid; Prodrugs; Rats; Rats, Sprague-Dawley; Refractometry; Solubility; Structure-Activity Relationship; Time Factors; Valproic Acid | 1999 |